Intraoperative molecular assay for sentinel lymph node metastases in early stage breast cancer: A comparative analysis between one-step nucleic acid amplification whole node assay and routine frozen section histology

Cancer

Volumn 117, Issue 19, 2011, Pages 4365-4374

  Osako, Tomo ^a   Iwase, Takuji ^a   Kimura, Kiyomi ^a   Yamashita, Kyoko ^a   Horii, Rie ^a   Yanagisawa, Akio ^b   Akiyama, Futoshi ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

breast cancer; frozen section histology; intraoperative diagnosis; micrometastasis; molecular assay; one step nucleic acid amplification assay; sentinel lymph node

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INVASION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FAT INVASION; FEMALE; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHOVASCULAR INVASION; MACROMETASTASIS; MAJOR CLINICAL STUDY; METASTASIS; MICROMETASTASIS; NUCLEIC ACID ANALYSIS; ONE STEP NUCLEIC ACID AMPLIFICATION ASSAY; POSTMENOPAUSE; PRIORITY JOURNAL; SENTINEL LYMPH NODE METASTASIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; COHORT STUDIES; DNA, NEOPLASM; FEMALE; FROZEN SECTIONS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PROGNOSIS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 80052034924     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26060     Document Type: Article

References (42)

1. Saphir O, Amromin GD,. Obscure axillary lymph-node metastasis in carcinoma of the breast. Cancer. 1948; 1: 238-241.
2. de Boer M, van Dijck JA, Bult P, Borm GF, Tjan-Heijnen VC,. Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases. J Natl Cancer Inst. 2010; 102: 410-425.
3. Krag DN, Weaver DL, Alex JC, Fairbank JT,. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993; 2: 335-339; discussion 40.
4. Giuliano AE, Kirgan DM, Guenther JM, Morton DL,. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994; 220: 391-398; discussion 98-401.
5. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL,. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 1995; 222: 394-399; discussion 99-401.
6. Weaver DL, Le UP, Dupuis SL, et al. Metastasis detection in sentinel lymph nodes: comparison of a limited widely spaced (NSABP protocol B-32) and a comprehensive narrowly spaced paraffin block sectioning strategy. Am J Surg Pathol. 2009; 33: 1583-1589.
7. Green FL, Amendoeira I, Apostolikas N,. American Joint Committee on Cancer Cancer Staging Manual. 6th ed. New York, NY: Springer; 2002.
8. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A,. American Joint Committee on Cancer Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010.
9. Layfield DM, Agrawal A, Roche H, Cutress RI,. Intraoperative assessment of sentinel lymph nodes in breast cancer. Br J Surg. 2011; 98: 4-17.
10. Tsujimoto M, Nakabayashi K, Yoshidome K, et al. One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res. 2007; 13: 4807-4816. (Pubitemid 47294788)
11. Visser M, Jiwa M, Horstman A, et al. Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer. Int J Cancer. 2008; 122: 2562-2567. (Pubitemid 351590490)
12. Schem C, Maass N, Bauerschlag DO, et al. One-step nucleic acid amplification-a molecular method for the detection of lymph node metastases in breast cancer patients; results of the German study group. Virchows Arch. 2009; 454: 203-210.
13. Tamaki Y, Akiyama F, Iwase T, et al. Molecular detection of lymph node metastases in breast cancer patients: results of a multicenter trial using the one-step nucleic acid amplification assay. Clin Cancer Res. 2009; 15: 2879-2884.
14. Notomi T, Okayama H, Masubuchi H, et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000; 28: E63.
15. Mori Y, Nagamine K, Tomita N, Notomi T,. Detection of loop-mediated isothermal amplification reaction by turbidity derived from magnesium pyrophosphate formation. Biochem Biophys Res Commun. 2001; 289: 150-154. (Pubitemid 33108807)
16. Breslow NE, Day NE,. Statistical methods in cancer research. Volume I-The analysis of case-control studies. IARC Sci Publ. 1980;(32): 5-338.
17. Tarone RE,. On heterogeneity tests based on efficient scores. Biometrika. 1985; 72: 91-95.
18. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing. Available at: Accessed on August 9, 2010.
19. Hansen NM, Grube B, Ye X, et al. Impact of micrometastases in the sentinel node of patients with invasive breast cancer. J Clin Oncol. 2009; 27: 4679-4684.
20. Wada N, Imoto S, Hasebe T, Ochiai A, Ebihara S, Moriyama N,. Evaluation of intraoperative frozen section diagnosis of sentinel lymph nodes in breast cancer. Jpn J Clin Oncol. 2004; 34: 113-117. (Pubitemid 43102901)
21. Truong PT, Vinh-Hung V, Cserni G, Woodward WA, Tai P, Vlastos G,. The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer. Eur J Cancer. 2008; 44: 1670-1677.
22. Chen SL, Hoehne FM, Giuliano AE,. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann Surg Oncol. 2007; 14: 3378-3384. (Pubitemid 350160103)
23. Wildiers H, Van Calster B, van de Poll-Franse LV, et al. Relationship between age and axillary lymph node involvement in women with breast cancer. J Clin Oncol. 2009; 27: 2931-2937.
24. Yu KD, Li JJ, Di GH, Wu J, Shen ZZ, Shao ZM,. A straightforward but not piecewise relationship between age and lymph node status in Chinese breast cancer patients. PLoS One. 2010; 5: e11035.
25. Kumar S, Bramlage M, Jacks LM, et al. Minimal disease in the sentinel lymph node: how to best measure sentinel node micrometastases to predict risk of additional non-sentinel lymph node disease. Ann Surg Oncol. 2010; 17: 2909-2919.
26. Rutgers EJ,. Sentinel node biopsy: interpretation and management of patients with immunohistochemistry-positive sentinel nodes and those with micrometastases. J Clin Oncol. 2008; 26: 698-702. (Pubitemid 351264381)
27. Menes TS, Tartter PI, Mizrachi H, Constantino J, Estabrook A, Smith SR,. Breast cancer patients with pN0(i+) and pN1(mi) sentinel nodes have high rate of nonsentinel node metastases. J Am Coll Surg. 2005; 200: 323-327. (Pubitemid 40298965)
28. Kamath VJ, Giuliano R, Dauway EL, et al. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. Arch Surg. 2001; 136: 688-692. (Pubitemid 32525473)
29. Viale G, Maiorano E, Pruneri G, et al. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg. 2005; 241: 319-325.
30. Bilimoria KY, Bentrem DJ, Hansen NM, et al. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol. 2009; 27: 2946-2953.
31. Langer I, Guller U, Viehl CT, et al. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study. Ann Surg Oncol. 2009; 16: 3366-3374.
32. Reed J, Rosman M, Verbanac KM, Mannie A, Cheng Z, Tafra L,. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study. J Am Coll Surg. 2009; 208: 333-340.
33. Pernas S, Gil M, Benitez A, et al. Avoiding axillary treatment in sentinel lymph node micrometastases of breast cancer: a prospective analysis of axillary or distant recurrence. Ann Surg Oncol. 2010; 17: 772-777.
34. Yegiyants S, Romero LM, Haigh PI, DiFronzo LA,. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node. Arch Surg. 2010; 145: 564-569.
35. Colleoni M, Rotmensz N, Peruzzotti G, et al. Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol. 2005; 23: 1379-1389.
36. de Boer M, van Deurzen CH, van Dijck JA, et al. Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med. 2009; 361: 653-663.
37. Bleiweiss IJ, Nagi CS, Jaffer S,. Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma. J Clin Oncol. 2006; 24: 2013-2018. (Pubitemid 46622109)
38. Corben AD, Nehhozina T, Garg K, Vallejo CE, Brogi E,. Endosalpingiosis in axillary lymph nodes: a possible pitfall in the staging of patients with breast carcinoma. Am J Surg Pathol. 2010; 34: 1211-1216.
39. Peng Y, Ashfaq R, Ewing G, Leitch AM, Molberg KH,. False-positive sentinel lymph nodes in breast cancer patients caused by benign glandular inclusions: report of 3 cases and review of the literature. Am J Clin Pathol. 2008; 130: 21-27; quiz 146.
40. Norton LE, Komenaka IK, Emerson RE, Murphy C, Badve S,. Benign glandular inclusions: a rare cause of a false positive sentinel node. J Surg Oncol. 2007; 95: 593-596. (Pubitemid 47164667)
41. Fisher CJ, Hill S, Millis RR,. Benign lymph node inclusions mimicking metastatic carcinoma. J Clin Pathol. 1994; 47: 245-247. (Pubitemid 24120688)
42. Chu PG, Weiss LM,. Keratin expression in human tissues and neoplasms. Histopathology. 2002; 40: 403-439. (Pubitemid 34535443)